Press Releases
All - 2010 - 2009 - 2008 - 2007 - 2006 - 2005
Records found: 101 Page: 1 of 11
Pierrel S.p.A.: Interim Consolidated Report as of June 30, 2010
27/08/2010
- Milan
Pierrel S.p.A.: Interim Consolidated Report as of June 30, 2010
Pierrel S.p.A.: The BoD approves the Interim Consolidated Report as of June 30,2010
27/08/2010
- Milan
Pierrel S.p.A.: The BoD approves the Interim Consolidated Report as of June 30,2010
Pierrel S.p.A.: The activities of the subsidiary Pierrel Research International AG begin
10/08/2010
- Milan
Pierrel S.p.A.: The activities of the subsidiary Pierrel Research International AG begin
Pierrel S.p.A.:Company Events Calendar Update
29/07/2010
- Milan
Pierrel S.p.A.:Company Events Calendar Update
Pierrel S.p.a.: Russian Regulatory Authority grants Pierrel S.p.A the Authorization to register its dental anesthetic drug “Pierrel Articaine”
11/06/2010
- Milan
Pierrel S.p.A.: Russian Regulatory Authority grants Pierrel S.p.A the Authorization to register its dental anesthetic drug “Pierrel Articaine”
Pierrel S.p.A.: Michael E. Laird appointed New Chief Executive Officer of Pierrel Research USA and Chief Marketing Officer of Pierrel Research International
01/06/2010
- Milan
Pierrel S.p.A.: Michael E. Laird appointed New Chief Executive Officer of Pierrel Research USA and Chief Marketing Officer of Pierrel Research International
Pierrel S.p.A.: The BoD approves Interim Report as at 31 March 2010
12/05/2010
- Milan
Pierrel S.p.A.: The BoD approves Interim Report as at 31 March 20
Pierrel S.p.A.: The BoD has approved the partial re-organization of the activities of Pierrel Group
12/05/2010
- Milan
Pierrel S.p.A.: The BoD has approved the partial re-organization of the activities of Pierrel Group
Pierrel S.p.A.: Company Events Calendar 2010
05/05/2010
- Milan
Pierrel S.p.A.: Company Events Calendar 2010
Pierrel S.p.A.: Shareholders' Meeting
27/04/2010
- Milan
Pierrel S.p.A.: Shareholders' Meeting
Previous page ¦ Next page



Pierrel Research is a Global CRO offering its customers services and support for all phases (I-II-III) of clinical drug development, phase IV, PMS and Observational studies.
Pierrel's manufacturing plant is located in Capua, 20km north of Naples. Pierrel owns 40.000 sqm of land of which 11.000 sqm is covered area.